Tenet Healthcare Corporation (THC)
NYSE: THC · IEX Real-Time Price · USD
134.24
+0.94 (0.71%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Tenet Healthcare Stock Forecast
Stock Price Forecast
The 17 analysts with 12-month price forecasts for Tenet Healthcare stock have an average target of 119.71, with a low estimate of 81 and a high estimate of 155. The average target predicts a decrease of -10.82% from the current stock price of 134.24.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for THC stock from 17 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 8 | 8 | 9 | 8 |
| Buy | 6 | 6 | 8 | 8 | 8 | 8 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 16 | 16 | 17 | 17 | 18 | 17 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $150 → $155 | Strong Buy | Maintains | $150 → $155 | +15.46% | Jun 28, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $107 → $140 | Buy | Maintains | $107 → $140 | +4.29% | May 30, 2024 |
| Deutsche Bank | Deutsche Bank | Strong Buy Maintains $126 → $150 | Strong Buy | Maintains | $126 → $150 | +11.74% | May 30, 2024 |
| Baird | Baird | Buy Initiates $153 | Buy | Initiates | $153 | +13.97% | May 30, 2024 |
| Barclays | Barclays | Buy Maintains $113 → $147 | Buy | Maintains | $113 → $147 | +9.51% | May 2, 2024 |
Financial Forecast
Revenue This Year
20.66B
from 20.56B
Increased by 0.47%
Revenue Next Year
21.49B
from 20.66B
Increased by 4.00%
EPS This Year
8.95
from 5.71
Increased by 56.78%
EPS Next Year
9.35
from 8.95
Increased by 4.44%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 22.5B | 23.3B | 24.6B | 24.5B | 25.5B |
| Avg | 20.7B | 21.5B | 22.6B | 23.5B | 24.5B |
| Low | 19.8B | 20.6B | 21.4B | 22.8B | 23.8B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 9.6% | 12.8% | 14.3% | 8.4% | 8.2% |
| Avg | 0.5% | 4.0% | 5.0% | 4.3% | 4.0% |
| Low | -3.8% | -0.5% | -0.6% | 1.2% | 0.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10.57 | 12.32 | 13.48 | 12.37 | 13.00 |
| Avg | 8.95 | 9.35 | 10.48 | 11.90 | 12.50 |
| Low | 8.07 | 7.95 | 8.82 | 11.54 | 12.13 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 85.1% | 37.6% | 44.2% | 18.1% | 9.3% |
| Avg | 56.8% | 4.4% | 12.1% | 13.6% | 5.1% |
| Low | 41.3% | -11.2% | -5.7% | 10.2% | 2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.